|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202.9 EGP | -10.01% |
|
-10.01% | -6.79% |
MINAPHARM Pharmaceuticals reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EGP 3,892.05 million compared to EGP 3,620.54 million a year ago. Net loss was EGP 31.99 million compared to net income of EGP 612.66 million a year ago.
Basic loss per share from continuing operations was EGP 5 compared to basic earnings per share from continuing operations of EGP 51.41 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.79% | 52.14M | |
| +19.27% | 43.75B | |
| +26.07% | 22.06B | |
| +15.11% | 14.46B | |
| +12.33% | 13.62B | |
| +38.36% | 11.61B | |
| -8.66% | 6.9B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.32B |
MINAPHARM PHARMACEUTICALS 
